BlackRock Health Sciences Trust (NYSE:BME) Sees Significant Decrease in Short Interest

BlackRock Health Sciences Trust (NYSE:BMEGet Free Report) was the target of a significant decline in short interest in March. As of March 13th, there was short interest totaling 67,055 shares, a decline of 17.4% from the February 26th total of 81,198 shares. Based on an average daily volume of 45,079 shares, the days-to-cover ratio is currently 1.5 days.

Hedge Funds Weigh In On BlackRock Health Sciences Trust

Large investors have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. grew its position in shares of BlackRock Health Sciences Trust by 22.2% during the third quarter. Northwestern Mutual Wealth Management Co. now owns 1,417 shares of the company’s stock worth $53,000 after purchasing an additional 257 shares in the last quarter. SOA Wealth Advisors LLC. boosted its stake in BlackRock Health Sciences Trust by 20.3% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 2,780 shares of the company’s stock worth $103,000 after purchasing an additional 469 shares during the period. Geneos Wealth Management Inc. boosted its stake in BlackRock Health Sciences Trust by 200.0% in the 2nd quarter. Geneos Wealth Management Inc. now owns 4,899 shares of the company’s stock worth $179,000 after purchasing an additional 3,266 shares during the period. Sage Investment Counsel LLC purchased a new stake in BlackRock Health Sciences Trust during the 3rd quarter valued at approximately $201,000. Finally, Truist Financial Corp bought a new stake in shares of BlackRock Health Sciences Trust during the third quarter valued at approximately $205,000.

BlackRock Health Sciences Trust Stock Performance

Shares of BME traded up $0.93 during mid-day trading on Wednesday, reaching $39.44. The stock had a trading volume of 24,496 shares, compared to its average volume of 41,946. The business has a fifty day moving average of $41.14 and a 200 day moving average of $40.06. BlackRock Health Sciences Trust has a 12 month low of $34.18 and a 12 month high of $42.74.

BlackRock Health Sciences Trust Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, June 15th will be paid a $0.2621 dividend. This represents a c) dividend on an annualized basis and a yield of 8.0%. The ex-dividend date is Monday, June 15th.

About BlackRock Health Sciences Trust

(Get Free Report)

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.

Featured Stories

Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.